Validation of prognostic indices using the frailty model
- 11 July 2008
- journal article
- research article
- Published by Springer Nature in Lifetime Data Analysis
- Vol. 15 (1) , 59-78
- https://doi.org/10.1007/s10985-008-9092-2
Abstract
A major issue when proposing a new prognostic index is its generalisibility to daily clinical practice. Validation is therefore required. Most validation techniques assess whether “on average” the results obtained by the prognostic index in classifying patients in a new sample of patients are similar to the results obtained in the construction set. We introduce a new important aspect of the generalisibility of a prognostic index: the heterogeneity of the prognostic index risk group hazard ratios over different centers. If substantial variability between centers exists, the prognostic index may have no discriminatory capability in some of the centers. To model such heterogeneity, we use a frailty model including a random center effect and a random prognostic index by center interaction. Statistical inference is based on a Bayesian approach using a Laplacian approximation for the marginal posterior distribution of the variances of the random effects. We investigate different ways to summarize the information available from this marginal posterior distribution. Our approach is applied to a real bladder cancer database for which we demonstrate how to investigate and interpret heterogeneity in prognostic index effect over centers.Keywords
This publication has 38 references indexed in Scilit:
- Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990–1999European Journal Of Cancer, 2007
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- A Bayesian approach to jointly estimate centre and treatment by centre heterogeneity in a proportional hazards modelStatistics in Medicine, 2005
- Understanding Heterogeneity in Generalized Mixed and Frailty ModelsThe American Statistician, 2005
- Construction and validation of a prognostic model across several studies, with an application in superficial bladder cancerStatistics in Medicine, 2004
- Modelling clustered survival data from multicentre clinical trialsStatistics in Medicine, 2004
- A Bayesian justification of Cox's partial likelihoodBiometrika, 2003
- Predictive accuracy and explained variationStatistics in Medicine, 2003
- The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic indexBritish Journal of Urology, 1998
- Accurate Approximations for Posterior Moments and Marginal DensitiesJournal of the American Statistical Association, 1986